LGVN · Longeveron Inc. · Exempt Offerings
$2.69
-0.03 (-1.10%)
At close · Sep 30
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We have prepared a cash flow forecast which indicates that we do not have sufficient cash to meet our minimum expenditure commitments for one year from the date these financial statements are available to be issued and therefore we need to raise additional funds to continue as a going concern. As a result, there is substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 12, 2026
Market Cap
$8.96M
Shares
3.19M
Volume · Sep 30
54.97K
Avg daily vol (24 sessions)
165.5K
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2026-03-25 | New | Biotechnology | $33,515,000 | $15,890,000 | 06b |
| 2024-07-23 | New | Biotechnology | $9,508,010 | $0 | 06b |
| 2024-06-25 | New | Biotechnology | $9,444,516 | $0 | 06b |
| 2024-04-25 | New | Biotechnology | $12,424,674 | $0 | 06b |
| 2024-01-08 | New | Biotechnology | $2,571,942 | $0 | 06b |
| 2023-10-24 | New | Biotechnology | $8,350,001 | $0 | 06b |
| 2021-12-13 | New | Biotechnology | $20,462,545 | $20,462,545 | 06b |
| 2020-02-06 | New | Biotechnology | $25,000,000 | $100,000 | 06b |
| 2020-02-06 | Amendment | Biotechnology | $25,000,000 | $954,970 | 06b |
Showing 1–9 of 9 filings